Učitavanje...
Brexpiprazole: so far so good
This article describes the role of a newly approved antipsychotic agent brexpiprazole in the treatment of schizophrenia and major depressive disorder. This drug has high affinity for 5-HT(1A), 5-HT(2A), D(2) and α(1B,2C) receptors. It displays partial agonism at 5-HT(1A) and D(2) receptors and poten...
Spremljeno u:
| Izdano u: | Ther Adv Psychopharmacol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4749739/ https://ncbi.nlm.nih.gov/pubmed/26913177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125315614739 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|